Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 5;19(1):879.
doi: 10.1186/s12885-019-6115-1.

The association between fecal enterotoxigenic B. fragilis with colorectal cancer

Fakhri Haghi  1 , Elshan Goli  1 , Bahman Mirzaei  1 , Habib Zeighami  2
Affiliations

The association between fecal enterotoxigenic B. fragilis with colorectal cancer

Fakhri Haghi et al. BMC Cancer. .

Abstract

Background: Enterotoxigenic Bacteroides fragilis (ETBF) is an enterotoxin-producing bacterium that possibily has a role in the occurrence and progression of colorectal cancer (CRC) by modulating the mucosal immune response and inducing epithelial cell changes. The aim of this study was to investigate the frequency of ETBF in stool samples of CRC patients and healthy volunteers.

Methods: A total of 60 stool samples from confirmed CRC patients and 60 stool samples from healthy volunteers with no personal or familial history or diagnosis of colorectal disease were collected. Stool samples were screened for direct detection of B. fragilis using PCR targeting the marker genes of neu and bft. Enterotoxin isotypes bft-1, bft-2 and bft-3 were also detected in B. fragilis positive samples.

Results: The frequency of B. fragilis among CRC and control cases was 58.3 and 26.6%, respectively (P < 0.05). The rate of bft gene in CRC cases was significantly higher than in controls (P < 0.05). Also, the presence of bft gene in CRC patients stage III was significantly higher than stages I and II (P < 0.05). Enterotoxin isotype bft-2 was detected with higher frequency among CRC patients than healthy control (P < 0.05).

Conclusion: Our results show the association between fecal ETBF and CRC, and we suggest that detection of ETBF may be a potential marker for colorectal cancer diagnosis. However, additional investigations on tumor and paired normal tissue samples are required to substantiate this possible correlation.

Keywords: Bacteroides fragilis; Colorectal cancer; Enterotoxin; Stool; bft gene.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Park CH, Eun CS, Han DS. Intestinal microbiota, chronic inflammation, and colorectal cancer. Intest Res. 2018;16(3):338–345. doi: 10.5217/ir.2018.16.3.338. - DOI - PMC - PubMed
    1. Liu C-J, Zhang Y-L, Shang Y, Wu B, Yang E, Luo Y-Y, Li X-R. Intestinal bacteria detected in cancer and adjacent tissue from patients with colorectal cancer. Oncol Lett. 2019;17(1):1115–1127. - PMC - PubMed
    1. Yu LC, Wei SC, Ni YH. Impact of microbiota in colorectal carcinogenesis: lessons from experimental models. Intest Res. 2018;16(3):346–357. doi: 10.5217/ir.2018.16.3.346. - DOI - PMC - PubMed
    1. Jahani-Sherafat S, Alebouyeh M, Moghim S, Ahmadi Amoli H, Ghasemian-Safaei H. Role of gut microbiota in the pathogenesis of colorectal cancer; a review article. Gastroenterol Hepatol Bed Bench. 2018;11(2):101–109. - PMC - PubMed
    1. Hale VL, Jeraldo P, Chen J, Mundy M, Yao J, Priya S, Keeney G, Lyke K, Ridlon J, White BA, et al. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers. Genome medicine. 2018;10(1):78. doi: 10.1186/s13073-018-0586-6. - DOI - PMC - PubMed

MeSH terms